News

Published on 27 Dec 2023 on Insider Monkey via Yahoo Finance

16 Most Promising Dividend Stocks According to Analysts


Article preview image

In this article, we discuss 16 most promising dividend stocks according to analysts. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Most Promising Dividend Stocks According to Analysts. 

This year brought a notable shift in the investment scene, where technology stocks surged ahead, overshadowing the performance of dividend-focused equities. Despite this change, experts advise that investors diversify their portfolios across various asset classes to navigate diverse market situations effectively. This strategy aims to ensure resilience against fluctuations and uncertainties in the market, emphasizing the importance of a well-rounded investment approach that goes beyond focusing solely on one sector or type of stock. Art Hogan, the chief market strategist at B. Riley Wealth, shared insights on investment strategies in an interview with Bloomberg. Here are some comments from the analyst:

“It’s clear that having a diversified portfolio is probably the best way to navigate the investment climate and the best way to do that is owning the S&P 500 — full stop. If you were to start this year by saying ‘everyone says there’s a recession coming so I’m going to invest defensively,’ you got punched in the nose.”

NYSE.BIP price evolution
NYSE.ABBV price evolution
LSE.AZN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
AbbVie's (NYSE:ABBV) Shareholders Will Receive A Bigger Dividend Than Last Year

AbbVie Inc. (NYSE:ABBV) will increase its dividend from last year's comparable payment on the 14t...

Simply Wall St. · via Yahoo Finance 17 Nov 2024

Why AbbVie’s (ABBV) Drug Setback Creates A Prime Buy-The-Dip Moment

AbbVie stock fell 10% after emraclidine, its drug for schizophrenia, failed during the final stag...

Insider Monkey · via Yahoo Finance 16 Nov 2024

Dividend King AbbVie Just Paid Investors: Here's How Much They Got

AbbVie Inc. (NYSE: ABBV) is rewarding its shareholders once again with a quarterly dividend of...

247wallst.com 16 Nov 2024

Health Stocks Slide as Trump Picks Industry Skeptic Kennedy

(Bloomberg) -- Health stocks slumped on Friday as Wall Street weighed the impact that prominent...

Bloomberg · via Yahoo Finance 15 Nov 2024

Robert Bruce's Strategic Moves in Q3 2024: Spotlight on AerCap Holdings NV

Key Position Reductions Conversely, reductions were made in several holdings: AbbVie Inc (NYSE:AB...

GuruFocus.com · via Yahoo Finance 14 Nov 2024

AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In...

On Monday, AbbVie Inc (NYSE:ABBV) stock plunged after two trials investigating emraclidine as a...

Benzinga · via AOL 12 Nov 2024

Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value

As of 2024-11-12, AbbVie Inc's intrinsic value as calculated by the Discounted Earnings model is...

GuruFocus.com · via Yahoo Finance 12 Nov 2024

AbbVie's Emraclidine For Schizophrenia 'Surprisingly Disappoints,' Analyst Says...

On Monday, AbbVie Inc ABBV stock plunged after two trials investigating emraclidine as a once-dai...

Benzinga 11 Nov 2024

AbbVie Tumbles After New Schizophrenia Drug Fails Two Trials

(Bloomberg) -- AbbVie Inc. shares fell the most in more than four years after two mid-stage trial...

Bloomberg · via Yahoo Finance 11 Nov 2024

AbbVie stock drops 12% on schizophrenia drug setback: buy the dip? | Invezz

AbbVie Inc (NYSE: ABBV) saw its stock fall nearly 13% after reporting disappointing mid-stage tri...

Invezz 11 Nov 2024